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The Delay in Diagnosis of Tuberculosis in the
Monteregie region of Quebec, Canada
Caroline Lacroix*†, Philippe Martin†, Sebastien Turcotte†, Steven
DeRoche†, Vanessa Magluilo† and Christine Lacroix‡
ABSTRACT: Introduction – Despite being more prevalent in developing countries, tuberculosis (TB)
remains an important health problem in Canada. Long diagnosis delays of respiratory tuberculosis are
associated with adverse consequences for the patient but also for the community. From a public health
perspective, identification of factors associated with long delays of diagnosis could help reduce these
delays. Objectives – 1)To describe diagnosis delays of respiratory tuberculosis in Monteregie 2)To
identify the characteristics of patients and factors associated with longer diagnosis delays 3)To identify
consequences of these delays Methods – The study is descriptive and transversal. Data were obtained
from notifiable diseases files of the Public Health Department of the Health and Social ServicesAgency
of Monteregie. The diagnosis delay was calculated using the first symptomatic date and the date of
diagnosis. For continued variable analyses, Student t tests and an ANOVA test were done. For
categorical variables, Pearson’s chi squared test and a Mann-Whitney test were done. Results – The
average delay of diagnosis for the 115 cases studied was 92.2 days (CI 80.6-103.8). Weight loss and/or
non specific general malaise were associated with a longer diagnosis delay. No association was found
between the diagnosis delay and possible consequences of longer delays. Discussion and conclusion:
Most patients had a diagnosis delay longer than two months. A larger study that would divide the total
diagnosis delay into a patient delay and a suspicion delay (health care system delay) could permit a
better identification of factors that favour long delays.
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INTRODUCTION
Tuberculosis epidemiology
The World Health Organisation (WHO) estimated that
almost one third of the global population was infected
by the tuberculosis bacillus in 2006.[1] Presently,
approximately 2 million people die each year of the
disease. The majority of cases occur in developing
countries, but the problem is still important in Canada,
despite a constant reduction of the disease incidence in
the past 20 years. The increase of immigrants born in
countries endemic for tuberculosis (TB) during the past
decades and the more prevalent resistance to treatment
in immigrants bring a new challenge to the anti-
tuberculosis plan. [1]
In Canada, the majority of new tuberculosis cases
occur in the first nation population and immigrants. [1]
In Monteregie, approximately 20 cases are declared
each year to the Public Health.[2] In 2006, 227 cases
were reported in Quebec, from which 19 cases occurred
in Monteregie. In Quebec, the incidence was of 3 cases
per 100 000; in Monteregie, it was of 1.4 case per 100
000. [3]
Diagnosis
There are 4 principal methods to establish diagnosis:
1. Pulmonary x-rays: sensitivity of 70 to 80%. [1]
2. Zhiel-Neelsen smear: fast (less than 2 days),
sensitivity with and without PCR of 95% and 60%,
respectively.Allows the evaluation of contagiousness of
the infected individual; the greater the number of
bacillus in each microscopic field, the more contagious
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the individual is. [1, 4]
3. PCR: in clinical use since approximately 15 years,
completed in 3 to 24 hours. Its sensitivity, around 80%,
is higher than that of the smear but lower than that for
the culture. [1]
4. Culture: The gold standard to establish the
diagnosis. Sensitivity around 90% for 3 sputum
cultures. However, it can take up to 6 weeks to obtain
results. [1, 4]
Patients with a positive smear result and those with a
pulmonary cavities on x-ray are more contagious than
other patients. [4]
Screening for contacts – Public health intervention
In Quebec, active tuberculosis is a disease that must
be mandatorily declared and treated. Because of the
potential severity of the disease and the consequences,
screening of close contacts of each respiratory
tuberculosis case is performed, to detect the presence of
disease or latent infection. This process requires human
and material resources and generates anxiety in contacts
being screened.
Delays of diagnosis
An important factor in the control of the disease is a
rapid diagnosis and instauration of an appropriate
treatment. A long delay is associated with a greater risk
for the patient to develop a more advanced disease, to
have more complications and a higher mortality. [5,6]
Also, an increase in the delay causes a higher risk for
the community because of the increased contagiousness
of the case: the longest delays are associated with larger
numbers of bacilli on the smears. [7,8] A systematic
review by Storla and al. [9] on delays of diagnosis of
tuberculosis described an average total delay of
diagnosis of 72 ﾱ 28 days.
These findings show that delays of diagnosis
represent a major concern for public health and that a
decrease in delays could reduce the consequences of
tuberculosis. For this reason, it is important to identify
factors associated with delays in diagnosis and
treatment of TB to make recommendations and develop
new methods or protocols to reduce these delays.
The total delay of diagnosis may be divided into
different delays. First, there is a delay between the first
symptom and the moment when the patient first makes
contact with the health care system (patient delay).
Next, a delay occurs between the first consultation with
a doctor and the beginning of laboratory investigations
for tuberculosis (suspicion delay). These two delays
combined together represent the pre-test delay. Finally,
a delay exists between the first sputum sampling and the
confirmation of the diagnosis, either by PCR or by
culture (test delay).
The principal factors associated with delays of
diagnosis include seropositivity to HIV, chronic cough
and/or chronic pulmonary disease, a negative smear
result, advanced age, female sex, a low socio-economic
status, substance abuse and an immigrant status. [9]
Considering this information, the goal of this study is
to describe the delays in diagnosis and treatment of
respiratory tuberculosis in Monteregie from 1998 to
2007, to identify factors associated to these delays and
to document some of the possible consequences
associated with a prolonged delay.
METHODS
Population studied
This cross sectional study includes contagious active
tuberculosis cases declared to the Public Health
Department (PHD) in Monteregie between January 1st
1998 and June 30th 2007. Because this study concerns
contagious tuberculosis, only the pulmonary, laryngeal
and miliary forms of the disease were included. The
extra-pulmonary cases of tuberculosis that had no
respiratory tract involvement were excluded. In order to
avoid duplicating data related to a single patient, only
the first episode of respiratory tuberculosis identified
for each patient in Monteregie during the period studied
was considered. The non-confirmed cases (clinical
cases, not confirmed by a positive culture or PCR test
for a tuberculosis agent) were also excluded to reduce
the information bias associated with a wrong diagnosis.
Because the primary objective of the study is to
describe the factors associated with delays of diagnosis
and treatment of tuberculosis in Monteregie,
incidentally found cases were excluded. These cases
have a delay of diagnosis of 0 days (the disease start
date being the same as the date of diagnosis) and could
lead to an underestimation of the delay of diagnosis in
symptomatic patients.
Variables studied
With the information available in the Tuberculosis
Epidemiologic Questionnaire of the Public Health
Department of the Health and Social Services Agency
of Monteregie, three important dates in the diagnostic
process of active tuberculosis have been identified: the
start date of the disease (which corresponds to the first
symptomatic day as recalled by the patient), the first
sampling date and the date of diagnosis. The date of
diagnosis is defined as the date that tuberculosis was
diagnosed for the first time by the treating physician; if
this date is unknown, the date of diagnosis was then
determined by the date that treatment began or the date
of the first positive test result (smear, culture). With
these dates, three delays can be evaluated: the pre-test
delay, the test delay, and the delay of diagnosis (Table126 McGill Journal of Medicine 2008
1). The data sources available do not identify the date
of the first consultation, making it impossible to
determine the patient delay and the delay of suspicion.
The delay of diagnosis was mostly chosen because it
includes the other two that are strongly correlated with
it (mostly the pre-test delay) and because the test delay
only represents a small fraction of the delay of
diagnosis.
With the available information in the diseases files,
the presence of an association between the following
factors and the duration of the delay of diagnosis was
studied (Table 2): year of diagnosis, the exposition of
the Health and Social Services Center (HSSC)
consulted by the patient to tuberculosis, sex, age, native
country (endemic or not) and the number of years since
the arrival in Canada in the cases of immigrants, the
presenting symptoms, the medical history and the
results of diagnostic tests (pulmonary x-rays, smears
and PCR).
A second objective of the study is to evaluate the
possible consequences of diagnosis and treatment
delays of tuberculosis. The four factors analysed to
evaluate consequences of the delay are : presence or not
Delay of diagnosis Number of days between the beginning of the
disease date and the diagnostic date, inclusively
Pre-test delay Number of days between the beginning of the
disease date and the first sputum sampling date,
inclusively
Test delay Number of days between the first sputum
sampling date and the diagnostic date,
inclusively
Patient delay Number of days between the beginning of the
disease date and the first consultation date
Suspicion delay Number of days between the first contact with
the health care system date and the first sputum
sampling date
HSSC with a high
exposition to
tuberculosis
A HSSC in Monteregie with an average of at
least 3 cases of tuberculosis each year between
2004 and 2006, according to the statistics from
the Public Health Department of Monteregie
[10,11,12].
Endemic native
country
A country with an estimated incidence of
positive smear tuberculosis of at least 30 cases /
100 000 between 2003 and 2005, according to
the Global Health Atlas of the WHO [13]
Number of years
since arrival in
Canada
Number of years between the diagnosis and the
arrival in Canada (for immigrants)
Presenting
symptoms
Symptoms included in the questionnaire : fever,
nocturnal sweats, weigh loss and/or non specific
general malaise, cough, expectorations,
haemoptysis, thoracic or pleuritic pain
Duration of
hospitalisation
Number of days between the admission date and
the end of hospitalisation, inclusively
Number of contacts Number of persons identified as being close
contacts of the index case of tuberculosis during
the standardized inquiry by the PHD
Proportion of
contacts with
positive TST
Proportion of index case close contacts that had
a TST result of 5 mm or more in one of the two
tests
Attribuable deaths Death directly caused by or favoured by
tuberculosis
Table 1: Variable Definitions
Socio-demographic
variables
Number
(%)a
Aver. delay
of diagnosis
(in days)
CI 95% p value
Sex
Men
Women
115
72 (62.6)
43 (37.4)
90.8
94.4
74.5-107.1 0.774c
Age
0-19years
20-39 years
40-64 years
>64 years
115
8 (7.0)
25 (21.7)
35 (30.4)
47 (40.9)
71.6
87.8
93.9
96.7
24.1-119.2
68.9-106.6
72.0-115.7
77.0-116.4
0.752d
HSSC
Low exposition
High exposition
115
52 (45.2)
63 (54.8)
94.5
90.2
74.9-114.1
76.4-104.0
0.719c
Native Country
Canada
Endemic country
Other
114
62 (54.4)
36 (31.6)
16 (14.0)
105.1
80.4
73.9
87.7-122.5
64.2-96.6
46.1-101.1
0.066c,e
0.102 c,f
# of years since
arrival in Canadab
0-5 years
>5 years
51
27 (52.9)
24 (47.1)
81.7
74.0
62.9-100.5
52.3-95.7
0.599c
Presenting
Symptoms
Fever & or
nocturnal sweat
Yes
No
115
66 (57.4)
49 (42.6)
99.1
82.8
82.9-115.3
66.6-99.0
0.175c
Weight loss & or
non-specific gen.
malaise
Yes
No
115
76 (66.1)
39 (33.9)
102.4
72.3
88.2-116.6
53.4-91.2
0.016c
Cough &/or
expectoration
Yes
No
115
91 (79.1)
24 (20.9)
95.1
81.0
82.0-108.2
56.3-105.7
0.335c
Haemoptysis
Yes
No
97
20 (20.6)
77 (79.4)
109.0
85.1
78.0-140.0
72.1-98.1
0.122b
Antecedents
Smoking
Yes
No
61
19 (31.1)
42 (68.9)
88.7
98.9
64.0-113.4
75.9-121.9
0.599c
Known contact w
TB pxt
Yes
No
94
40 (42.6)
54 (57.4)
88.8
91.1
68.4-109.2
75.0-107.2
0.865c
HIV sero(+)ve & or
immunosupp.
Yes
No
71
7 (9.9)
64 (90.1)
112.3
85.5
51.4-173.2
70.4-100.6
0.295c
Stay in an endemic
country
Yes
No
105
40 (38.1)
65 (61.9)
82.9
94.1
64.9-100.9
79.2-109.0
0.356c
Paraclinic Tests
Chest Xray result
Norm or Abnorm
Abnorm Cavitary
115
88 (76.5)
27 (23.5)
91.0
95.9
77.9-104.1
70.8-121.0
0.729c
Smear
Positive
Negative
111
67 (60.4)
44 (39.6)
93.7
89.3
79.7-107.7
69.7-108.9
0.711c
PCR
+ or -
No PCR done
115
77 (67.0)
38 (33.0)
89.3
97.9
76.4-102.2
74.2-121.6
0.498c
Table 2: Delays of diagnosis in relation to the different variables
studied.
a Proportion expressed in percentage of the total of valid cases for
each variable; b For immigrants only; c Student t test; d ANOVA test;
e Comparison of the average delays of diagnosis between Canadian
born patients and foreign-born patients of endemic countries; f
Comparison of the average delays of diagnosis between Canadian
born patients and foreign-born patients of non-endemic countries
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of hospitalisation of the patient and its duration if
present, total number of contacts, proportion of contacts
with a positive TST and the number of deaths attributed
to tuberculosis (caused entirely or partially by
tuberculosis).
Measurement instrument and data collection
Data collection was realised with a data gathering tool
elaborated from the available information in the
notifiable diseases files of the patients ( Appendix 4).
The information used in this study was obtained from
the Tuberculosis Epidemiologic Questionnaire
(Appendixes 5,6) which is an integral part of the
standardized inquiry of the PHD and is filled out for all
cases of tuberculosis reported in Monteregie. This
document is kept in the archives of the transmissible
diseases program of the PHD of Monteregie.
To confirm the validity of the data gathering tool
elaborated and to reduce the inter-observer variability, it
was pre-tested on 15 cases chosen randomly, after
which minor modifications were done and a consensus
on the way to collect data was established. The cases
used for the pre-test were not eliminated from the study
because the data gathering tool is used to review files,
not to survey patients (results are therefore not
influenced by question formulation).
When imprecise dates were reported in the patient
files, for example “beginning of the month”, “middle of
month” or “end of month” it was decided to transcribe
them as the 1st, the 15th or the 30th (28th for February)
of the month, respectively. Data not found in the
questionnaires were transcribed as “unknown”.
The information obtained with the data gathering tool
was then transferred in a data bank using the program
“Statistical Package for Social Sciences (SPSS) version
15.0. (SPSS Inc, Chicago)” A complete verification of
the data bank was done to minimise transcription errors.
Analysis
To establish the statistical signification of the results
obtained, a Student t test was done for the analysis of
continuous variables, such as factors associated with
delays of diagnosis. An ANOVA test was used for the
evaluation of the delay in diagnosis as a function of
patient age. A Mann-Whitney test was used to analyse
the number of close contacts as a function of the delay
in diagnosis, because the values taken by the first
variable deviated largely from a standard distribution.A
Pearson Chi-squared test was used to analyse
nominative variables. For each statistical test done, the
signification threshold was fixed at 0.05.
Ethical aspects
This study was done under the supervision the Public
Health Department of Monteregie and its objective is
part of the public health mandate. The confidentiality of
the cases studied was preserved with many precautions,
including non nominative data collection.
RESULTS
A total of 206 cases of TB were declared to the PHD
of Monteregie between January 1st 1998 and June 30th
2007. From this number, 65 were non-respiratory TB
and 7 respiratory cases were clinical ones not confirmed
by culture or PCR. There were 134 cases of active
tuberculosis validated. From this number, 11 were
incidentally found and were excluded for the study.
Eight others were excluded during data collection: 4
files were not found at the time of data collection, a fifth
case was excluded because the file was incomplete,
another was excluded because the delay of diagnosis
could not be determined (the first symptomatic date was
not identified) and the last two cases were in fact
recurrences in patients with a previous episode of TB
already declared to the PHD of Monteregie. The
population studied represents a total of 115 cases.
Description of the population studied
All of the cases presented at least one pulmonary TB
component. For the immigrants, the median number of
years between arrival in Canada and the diagnosis was
5 years. Table 2 presents the principal characteristics of
the cases studied. The population is composed of a
larger number of men compared to women, of people
mostly aged more than 40 years and of people mostly
native from Canada.
Delays of diagnosis
The different delays analysed in this study are
presented in table 3. The average delay of diagnosis is
92.2 days and the median delay is 83.0 days.
Factors associated with the delay of diagnosis
Many factors were analysed to evaluate the presence
of association with the length of the delay of diagnosis.
None of the sociodemographic variables studied (sex,
age, HSSC and native country) were statistically
significantly associated with differences in the delay of
diagnosis. Individuals native from endemic countries
for tuberculosis seemed to have a shorter delay of
diagnosis than those born in Canada; the p value found
for this relation is near but not below the 0.05 threshold.
Only one presenting symptom studied was
statistically associated with a delay of diagnosis: weight
loss and/or non specific general malaise was associated
with a longer delay of diagnosis (102.4 days) than if that
symptom is absent at presentation (72.3 days).128 McGill Journal of Medicine 2008
Possible consequences of delays of diagnosis
To evaluate the presence of an association between
possible consequences of delays of diagnosis studied
and the delay of diagnosis, delays were classified as
long or short. The results of the study show that a delay
of diagnosis of 100 days coincided with the 64th
percentile. It was arbitrarily decided that a delay of 100
days or more was a long delay and that a delay of less
than 100 days was a short delay.
None of the possible consequences of delays of
diagnosis (number of contacts, presence or absence of
hospitalisation and number of days of hospitalisation)
were related to the duration of the delays. The overall
proportion of positive TCT results for close contacts of
the index case was compared to an analysis that
included only cases with patients native from an
endemic country for TB. There was no significant
difference in the results obtained.
DISCUSSION
This study describes for the first time delays in
diagnosis and treatment of tuberculosis in Monteregie.
During the period studied, the population of confirmed
tuberculosis cases is nearly complete because
laboratories declared all cases of the disease,
tuberculosis being subject to mandatory declaration.
Discussion of results
The average delay of diagnosis was 92.2 days and is
similar to results obtained in the systematic review by
Storla et al. [9] (72 days ﾱ 28 days).
In the notifiable diseases files of patients, the date of
first consultation was not available. It was impossible to
divide the total delay of diagnosis into patient and
suspicion delay as was often done in other studies. In
some studies [14,15], it was found that the two delays
were not influenced by the same factors and that a
particular factor could influence the two delays in
opposite ways. For example, being an immigrant can
increase the patient delay but reduces the delay of
suspicion; the final effect on delay of diagnosis is
therefore difficult to predict.
For the relation between the delay of diagnosis and
patient age, a tendency of increased delay was observed
with older patients using four age sub-divisions (shown
in Table 2). This observation is reported in other studies
[9], where an advanced age is a risk factor for a longer
delay of diagnosis. This relation was not statistically
significant, but motivated a second analysis with only
two age divisions: less than 40 years and 40 years or
older. This second analysis in turn did not show a
statistically significant result.
No significant relation was observed between the
exposition of the Health and Social Services Center to
tuberculosis and the delay of diagnosis. It was believed
that the HSSC with a higher exposition to the disease
would have shorter delays of diagnosis. However, an
information bias exists since the HSSC identified for
each patient is established with the patient address at the
time he had the disease and is therefore not necessarily
the one where the patient first consulted a doctor. Also,
the number of cases of TB in all HSSC is small, the
largest number of cases per HSSC being 10 per year.
The difference between HSSC is likely minimal.
In this study, a shorter average delay of diagnosis
(80.4 days) was observed for immigrants native from an
endemic country (a country with an estimated incidence
of positive smear tuberculosis of at least 30 cases / 100
000) than for patients born in Canada (105.1 days). The
p value for this relation, at 0.066, is not below the 0.05
Delays Median delay
(days)
Average delay
(days)
CI 95% Range
(days)
Delay of
diagnosis
83.0 92.2 80.6-103.8 (3, 344)
Pre-test
delay
61.0 76.1 64.9-87.3 (0, 335)
Test delay 7.0 15.0 11.6-19.4 (-4, 133)
Table 3: The different delays analysed in this study
Short Delay Long Delay p value
Contacts
Number of cases concerned (%)a
Average number of contacts (CI 95%)
Median number of contacts
64 (61.5)
15.1 (7.1-23.2)
7.0
40 (38.5)
13.7 (10.5-16.8)
13.0
0.123
Positive TST results among close contacts
Number of cases concerned (%)a
Average proportion of +ve results among close contacts (CI 95%)
60 (60.6)
0.419 (0.329-0.509)
39 (39.4)
0.393 (0.303-0.483)
0.703
Hospitalisation
# of pxts hospitalised (%)a
# of pxts non hospitalised (%)a
50 (68.5)
21 (52.5)
23 (31.5)
19 (47.5)
0.107
Average duration of hospitalisation (days) (CI 95%) 25.9 (18.8-33.0) 26.5 (8.9-44.1) 0.951
Outcome of the disease
Healing (%)a
Death (%)a
56 (64.4)
9 (0.6)
31 (35.6)
6 (0.4)
0.776
Table 4: The possible consequences studied in relation to delays of diagnosis
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threshold. It is possible that the number of cases studied
was not sufficient to establish a statistically significant
association. This relation, if found to be true, could be
explained by the fact that clinicians will include
tuberculosis in their differential diagnosis more readily
in an foreign born than in a Canada born patient because
the disease is less prevalent in Canada. This hypothesis
is supported by other studies [14,15,16] that show the
health care system associated delay is shorter for
foreign patients.Aprevious stay in an endemic country,
which was also verified in each case, seemed to follow
this trend.
A longer delay of diagnosis was observed in the
presence of each presenting symptom. These relations
were not statistically significant except for the weight
loss and/or non specific general malaise (p value of
0.016.) This is not consistent with the current literature
where certain symptoms are associated to longer delays
(ex: cough) and other with shorter delays (ex: fever)
[9,17]. These observations could be explained by the
fact that a long delay of diagnosis favours disease
progression and therefore symptom appearance. Also,
non-specific symptoms could lead to longer suspicion
delays by the clinician.
Smoking, a known contact with a tuberculous patient,
and a stay in an endemic country are not significantly
associated with a shorter delay of diagnosis. It was
believed that the presence of certain medical conditions
would lead to shorter delays of diagnosis. First,
smoking is associated to lung cancer. Tuberculosis and
lung cancer share many symptoms: cough,
haemoptysis, weight loss, etc. Clinicians who face a
patient that smokes and presents some of these
symptoms have to rule out lung cancer, requiring a more
in-depth investigation. However, an information bias
for smoking is probably present, because this
information was not systematically indicated in all the
questionnaires. The hypothesis of a shorter delay in
patients with a known contact with another tuberculosis
case or a stay in an endemic country came from the
assumption that clinical suspicion would be higher in
these patients. However, clinicians might not ask their
patients these important questions.
Smear results and pulmonary x-ray results do not
significantly influence the delay of diagnosis.Apositive
smear result or a cavitary pulmonary x-ray is logically
associated with a faster diagnosis. However, the
absence of such an observation in this study could be
due to a long delay before consultation with a doctor or
to a longer suspicion delay by the clinician, prolonging
the delay of diagnosis. Use of PCR for investigating
tuberculosis reduces the average delay of diagnosis in
the cases studied, but the relation is not significant.
For the possible consequences of delays of diagnosis,
the median number of contacts increases with the
duration of the delay but the relation is not statistically
significant. The number of contacts retrieved in the
patient file depends on the extent of the inquiry made by
the PHD and depends on the social environment (work,
school, family, etc.) of the index case. The number of
investigated contacts is possibly more dependant on
social environment than on the duration of the
contagious period. This hypothesis cannot be verified
with the available data.
The proportion of infected contacts (established by a
positive TST result) would logically be higher if the
contagious period is prolonged, but the contact lists
retrieved in patient files were often incomplete and a
recall bias is therefore possible. A more structured
contact list separating close contacts from other
contacts could offer more interesting research data.
Interestingly, division according to native country did
not modify the relation observed.
Hospitalized patients often have a shorter delay of
diagnosis, but the relation observed is not significant.
This could be explained by the fact that hospitalization
permits a faster management of the patient and favours
a faster diagnosis. A study of a larger population is
suggested to obtain a statistically significant relation.
There is no significant difference of treatment
outcome (recuperation or death) between the long and
short delay groups. Three cases were diagnosed post-
mortem making the delay of diagnosis difficult to
establish because the first symptom date is not known.
The number of deaths caused or favoured by TB is
limited. A larger study should be done to determine the
association between delay of diagnosis and treatment
outcome.
Principal limitations of study
Exclusion of clinical cases (not confirmed by culture
or PCR results) reduces the number of cases studied.
Also, these cases may have longer delays of diagnosis
and the factors associated with them could be different.
However, the number of these case is limited (only 7)
and is not significant compared to the total number of
cases studied (115).
Even if the data bank used included all the respiratory
cases of tuberculosis declared in Monteregie between
1998 and June 2007, the statistical power of the study is
low; the number of cases may be insufficient to obtain
other statistically significant associations.
This study, being descriptive and transversal, cannot
establish links of causality between the variables
studied. It is only possible to identify the presence of an
association between them.
The date when the disease began, needed to establish
the delay of diagnosis, is determined by asking the130 McGill Journal of Medicine 2008
patient to identify the moment where he or she first
noticed symptoms. This could result in a recall bias
because the patient does not necessarily remember the
precise date of symptom appearance.Also, it is difficult
to determine if that symptom was really caused by TB.
Secondary utilisation of data in this study can result in
a recall bias. For most variables, the fact that questions
were asked in an inquiry context rather than for research
purposes probably did not significantly influence the
results. However, for certain questions, the lack of strict
term definitions and questions asked with different
wording can diminish the value of the information
obtained.
External validity
The external validity of the study is good enough to
extend the results obtained to the population of
Monteregie for the next years, because all confirmed
cases of pulmonary TB during the studied years were
included. However, results cannot be extended to other
regions, because sociodemographic characteristics of
the population and healthcare organization may vary
from those found in Monteregie.
CONCLUSION AND RECOMMENDATIONS
The average delay of diagnosis of TB in Monteregie
between January 1st 1998 and June 30th 2007 is similar
to delays described in the literature. [9] Weight loss
and/or non specific general malaise are associated to a
longer delay of diagnosis. No other factors associated to
delays were statistically significant. No possible
consequence analysed could be attributed to a longer
delay. Limits of the study have to be considered; these
include a population possibly too small to obtain
statistically significant results for the analyses made.
Recommendations
1. This study, being descriptive and transversal, does
not allow the identification of factors of causality
between delays in diagnosis and factors associated to
these delays or consequences of these delays. In
addition, most results were not statistically significant,
making it difficult to determine factors that could help
in the early diagnosis of TB. However, since the delays
in diagnosis of TB remain long, physicians should be
informed on the importance of an early diagnosis and
thus a high clinical suspicion of TB.
2. A systematic tool to trace contacts and gather
follow-up information would be useful for future
studies. Asummary sheet organising patients according
to the relative importance of their contact with the index
case would give a better appreciation of the chain of
contagiousness and allow more easy access to the
relevant information.
3. The first consultation date could be added to public
health TB questionnaires in order to differentiate patient
delays from health care system delays. This
information would allow a better determination of the
relative importance of each type of delay, and a better
identification of interventions to correct factors causing
delays in diagnosis of TB.
ACKNOWLEDGMENTS
The original study was done by five third grade
medical students of the Universit￩ de Sherbrooke,
during their public health training of the medical
internship in the Public Health Department of the
Health and Social Services Agency of Monteregie.
They also thank everyone that contributed in a certain
way to the accomplishment of this work: Mrs Caroline
G￩linas, technician in psychosocial study; Mrs Ginette
Lagarde, public health nurse; Dr ￉ric Levac, consulting
physician of the transmissible diseases sector.
REFERENCES
1. Agence de la sant￩ publique du Canada. Normes
Canadiennes pour la lutte antituberculeuse 6e ￩dition – 2007.
http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tbstand07-fra.php
2. Direction de la sant￩ publique de la Monteregie, Bulletin
Sentinelle, ann￩es 2003 ￠ 2006.
http://www.rrsss16.gouv.qc.ca/Menu_Gauche/4-Publications/2-
Bulletins/Bulletins_de_la_Sante_publique/Sentinelle/sentinelle
_theme.html
3. Agence de la sant￩ publique du Canada. La tuberculose au
Canada – 2006, pr￩diffusion. http://www.phac-
aspc.gc.ca/publicat/2007/tbcanpre06/index-fra.html
4. Southwick FS. Pulmonary infections. In: Southwick FS, editor.
Infectious Diseases in 30 days. United states of America,
McGraw Hill; 2003. P 107-153
5. Zafran N, Heldal E, Pavlovic S, Vuckovic D, Boe J. Why do our
patients die of active tuberculosis in the era of effective therapy?
Tubercle and Lung Disease. 1994; 75(5): 329-333.
6. Enarson D. Failure of diagnosis as a factor in tuberculosis
mortality CMAJ. 1978; 118 : 1520-1522.
7. Madebo T, Lindtjorn B. Delay in treatment of pulmonary
Ttuberculosis : An analysis of symptom duration among
Ethiopian patients. Medscape General Medicine. 1999: E6.
8. El-Sony A, Enarson D, Khamis A, Baraka O, Bjune G.
Relations of grading of sputum smears with clinical features of
tuberculosis in patients in routine practice in Sudan. Int J
Tuberc Lung Dis. 2002; 6(2): 91-97.
9. Storla DG. Yimer S. Bjune GA. A systematic review of delay in
the diagnosis and treatment of tuberculosis. BMC Public Health.
2008; 8(1) : 15-22.
10. Perron L, Levac E et al. Rapport annuel 2006 - Les maladies
infectieuses en Mont￩r￩gie, incluant les maladies ￠ d￩claration
obligatoire (MADO). Agence de la sant￩ et des services sociaux
de la Mont￩r￩gie, juin 2007.
http://www.rrsss16.gouv.qc.ca/Menu_Gauche/4-Publications/3-
Monographies_Orientations_Rapports/Maladies_transmissibles
/dsp_pub_rap_mado_2006.pdf
11. Lina Perron, Louise de la Boissi￨re et al. Les maladies
infectieuses en Mont￩r￩gie, incluant les maladies ￠ d￩claration
obligatoire (MADO) – Rapport annuel 2005. Agence de la sant￩
et des services sociaux de la Mont￩r￩gie, juin 2006.Delay in Diagnosis of TB in the Monteregie region 131 Vol. 11 No. 2
http://www.rrsss16.gouv.qc.ca/Menu_Gauche/4-Publications/3-
Monographies_Orientations_Rapports/Maladies_transmissibles
/dsp_pub_rap_mado_2005.pdf
12. ￉ric Levac, Julie Loslier et al. Maladies ￠ declaration
obligatoire d’origine infectieuse – Rapport annuel 2004.
Agence de d￩veloppement de r￩seaux locaux de services de
sant￩ et de services sociaux, avril 2005.
http://www.rrsss16.gouv.qc.ca/Menu_Gauche/4-
Publications/3Monographies_Orientations_Rapports/Maladies_
transmissibles/dsp_pub_rap_mado_2004.pdf
13. World Health Organisation. Communicable diseases,
Tuberculosis. http://www.who.int/globalatlas/dataQuery/
default.asp
14. Fara MG, Rygh JH, Steen T.W, Selmer R, Heldal E, Bjune G.
Patient and health care system delays in the start of tuberculosis
treatment in Norway. BMC Infectious Diseases. 2006; 6(33).
15. Gagliooti C, Resi D, Moro ML. Delay in the treatment of
pulmonary TB in a changing demographic scenario,
International Journal of Tuberculosis and Lung Disease. 2006;
10(3): 305-309.
16. Rodger A, Jaffar S, Paynter S, Hayward A, Carless J, Maguire
H. Delay in the Diagnosis of Pulmonary Tuberculosis., London,
1998-2000 : Analysis of surveillance data. BMJ. 2003;
326(7395): 909-910.
17. Sanz B, Blasco T. Variables associated with diagnostic delay in
immigrant groups with tuberculosis in Madrid. International
Journal of Tuberculosis and Lung Disease. 2007; 11(6): 639-
646.
Caroline Lacroix (M.D. 2009) is currently an M.D. student at the Universit￩ de Sherbrooke.
Philippe Martin (M.D. 2009) is currently an M.D. student at the Universit￩ de Sherbrooke.
Sebastien Turcotte (M.D. 2009) completed four years of undergraduate studies in the fields of science and
engineering at the University of Ottawa. He is currently an M.D. student at the Universit￩ de Sherbrooke.
Vanessa Magluilo (M.D. 2009) is currently an M.D. student at the Universit￩ de Sherbrooke.
Steven DeRoche (M.D. 2009) is currently an M.D. student at the Universit￩ de Sherbrooke.
Christine Lacroix (M.D., M.Sc.) is a community medicine specialist working in infectious diseases control at
the Direction de sant￩ publique de la Mont￩r￩gie.